Humana Inc. (NYSE:HUM) Shares Bought by Jennison Associates LLC

Jennison Associates LLC lifted its stake in shares of Humana Inc. (NYSE:HUM) by 4.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 333,725 shares of the insurance provider’s stock after acquiring an additional 13,945 shares during the quarter. Jennison Associates LLC’s holdings in Humana were worth $105,704,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. Creative Financial Designs Inc. ADV grew its position in Humana by 244.0% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 86 shares of the insurance provider’s stock worth $27,000 after purchasing an additional 61 shares during the last quarter. CarsonAllaria Wealth Management Ltd. lifted its holdings in Humana by 111.4% in the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after purchasing an additional 39 shares in the last quarter. Atwood & Palmer Inc. acquired a new stake in Humana during the third quarter worth approximately $29,000. Ashton Thomas Securities LLC purchased a new position in shares of Humana during the 3rd quarter worth $31,000. Finally, Your Advocates Ltd. LLP increased its stake in Humana by 81.8% during the third quarter. Your Advocates Ltd. LLP now owns 100 shares of the insurance provider’s stock worth $32,000 after acquiring an additional 45 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on HUM shares. UBS Group cut their target price on shares of Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $395.00 price target on shares of Humana in a report on Tuesday, October 1st. Barclays upped their price target on shares of Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 31st. Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective for the company in a research report on Tuesday, October 8th. Finally, KeyCorp started coverage on shares of Humana in a research report on Friday, October 11th. They issued a “sector weight” rating for the company. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average price target of $315.86.

Humana Stock Up 5.8 %

NYSE HUM opened at $294.02 on Thursday. The stock’s 50 day simple moving average is $277.86 and its 200 day simple moving average is $331.03. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. Humana Inc. has a one year low of $213.31 and a one year high of $527.18. The firm has a market cap of $35.40 billion, a PE ratio of 26.04, a price-to-earnings-growth ratio of 2.17 and a beta of 0.52.

Humana (NYSE:HUM) last released its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. The company had revenue of $29.30 billion during the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. As a group, sell-side analysts forecast that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.20%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s payout ratio is 31.36%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.